Cowen — Merger or Acquisition (February 2013)
18 slides from Cowen's merger presentation, Feb 4, 2013
Slide 1: Investor Presentation on the Acquisition of Dahlman Rose & Co.
February 4, 2013 Cowen Group, Inc. Investor Presentation on the Acquisition of Dahlman Rose & Co.
Slide 2: Cautionary Notice Regarding Forward-Looking Statements
Cautionary Notice Regarding Forward-Looking Statements This presentation may contain forward-looking statements including statements relating to the market opportunity and future business prospects of Cowen and Dahlman Rose. Such statements are subject to certain risks and uncertainties that could c
Slide 3: Cowen client commitment quote
3 “At Cowen, we are dedicated to providing our clients with access to unparalleled domain knowledge, thoughtful advice and practical insights that will enable them to be better investors, business operators and decision makers.”
Slide 4: Transaction Details
4 Transaction Details Transaction Cowen Group to acquire 100% of issued and outstanding equity of Dahlman Rose Definitive agreement signed; approved by Cowen Group Board of Directors Consideration • All-stock; financial terms undisclosed Approvals Subject to customary closing conditions and regulato
Slide 5: Cowen & Company – The Premier Growth Investment Bank
5 Cowen & Company – The Premier Growth Investment Bank A research-driven, growth-oriented investment bank focused on 4 sectors: healthcare, technology/media/telecom, A&D/industrials and consumer Research 29 research analysts covering 400+ companies Equity Sales and Trading 130+ sales and trading pro
Slide 6: Strategically Compelling Combination
6 Strategically Compelling Combination Highly Complementary Businesses Ability to expand client reach, without compromising quality of product or service Banking - Significant opportunity to cross sell Cowen equity and debt capital markets capabilities Equities - Deep buy side relationships – overla
Slide 7: Culturally Aligned Organizations are a Positive for Integration
7 Culturally Aligned Organizations are a Positive for Integration Clients Shared commitment to exceptional level of client services Focused on building strong and lasting client relationships Best performers from both Cowen and Dahlman Rose will drive future growth Banking Cowen’s Co-heads of Invest
Slide 8: Cowen Has Successfully Integrated A Number of Significant Transactions
8 Cowen Has Successfully Integrated A Number of Significant Transactions Acquired KDC Securities – September 28, 2012 Financial terms of transaction undisclosed Acquired Algorithmic Trading Management - January 17, 2012 Financial terms of transaction undisclosed Acquired LaBranche & Co Inc. – Februa
Slide 9: Investment Banking and Capital Markets – Already Top Non-Bulge Equity Underwriter
9 Investment Banking and Capital Markets – Already Top 10 Non-Bulge Equity Underwriter in Core Sectors + Note: ECM Analytics as of December 31, 2012. Includes priced IPOs and follow-ons in Cowen sectors from issuers with market values less than $5 billion. Excludes registered directs and PIPEs. Cowe
Slide 10: Investment Banking and Capital Markets – Greenfield Opportunities in DCM and ECM
Investment Banking and Capital Markets – Greenfield Opportunities in DCM and ECM Source: CapitalIQ. Excludes bulge banks. Average Annual Capital Markets Opportunity (Ex-Bulge Banks) Sector Ttl Capital Mkts Transaction Value ($MM) (3Y) Number of Transactions (3Y) Avg Value per Transaction ($MM) Avg F
Slide 11: Cowen Has Become a Market Leader In Its Focus Sectors
11 In the Last 3 Years, Cowen Has Become a Market Leader In Its Focus Sectors – The Same Can Be Done With the Natural Resources Supply Chain Sectors Source: ECM Analytics as of December 31, 2012. Includes priced IPOs and follow-ons in Growth sectors from issuers with market values less than $3 billi
Slide 12: US Research Platform: An Even Stronger Research Team
12 US Research Platform 7 An Even Stronger Research Team Dahlman Rose’s best in class research team brings the combined organization’s senior research analyst total to 40 HEALTHCARE Christine Arnold Managed Care Ken Cacciatore Pharmaceuticals/ Specialty Josh Jennings, MD Medical Supplies & Devices P
Slide 13: US Research Platform – Authoritative Leader in Growth Equities
13 US Research Platform – Authoritative Leader in Growth Equities in the US US Equity Research Platform - # of Companies Under Coverage #15 & #20 in McLagan Rankings # Equity Analysts by Sector Source: Starmine, Thomson Reuters, August 2012, based on US companies under coverage. Cowen and Dahlman Ro
Slide 14: US Equity Sales and Trading Platform — Deeper Relevance to Institutions
14 US Equity Sales and Trading Platform — Deeper Relevance to Institutions Combined organization solidifying a top spot among the non-bulge US brokers Further distinguishing ourselves from the competition Bulge Bracket Non-Bulge Composite U.S. Trading Vol. 2009-2012 + Composite U.S. Trading Vol. 200
Slide 15: Equities Trading Volume per Research Analyst — Peer Comparison
15 Equities Trading Volume per Research Analysts — Peer Comparison Our sales and trading team are more relevant than our peer group with substantially more trading volume per analyst We expect this measure to increase further once the Dahlman Rose is fully integrated onto the Cowen platform Composit
Slide 16: We've Reshaped Cowen and Company in the Past Two Years
16 We’ve Reshaped Cowen and Company in the Past Two Years... Enhancing Banking and Capital Markets Platform Recruited talented investment banking and capital markets individuals Focus efforts on Cowen’s 4 core verticals where the firm has the greatest impact Added new product capabilities such as fi
Slide 17: This Transaction Has the Ability to Further Strengthen Cowen's Platform
...And This Transaction Has the Ability to Further Strengthen Cowen’s Platform III. COWEN AND COMPANY This transaction is about execution - something that the team at Cowen has experience doing That experience is fundamental to Cowen’s ability to further transform the Cowen platform through the acqu
Slide 18: Questions?
18 Questions?